Quality and Contamination: What's Actually in Your Supplement

This is the deeper companion piece to Why Most Supplements Don't Work (And Why You Still Feel Better). If the placebo-effect piece explains why supplements feel like they work, this piece explains why even when a supplement does have real pharmacology, the bottle on the shelf may not contain what the label says. This is the buyer-beware data, laid out without spin. Read it once, and the next time you see a viral supplement post, you will be able to recognize the patterns that produce the bad outcomes.

The regulatory frame matters

Dietary supplements in the United States are not regulated like drugs. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), supplements are treated as a category of food. The FDA does not approve them before they go to market, does not verify their identity or potency before sale, and acts almost entirely reactively - investigating only after adverse events, consumer complaints, or surveillance sampling raises a red flag. The practical consequence is that the burden of quality control falls on the manufacturer's voluntary good practices and on third-party verification programs. For brands that take this seriously, the result is acceptable. For brands that do not, the result is the data below.

The FDA tainted supplements database

The FDA maintains a public Tainted Products Marketed as Dietary Supplements database. An analysis of the 2007-2021 data identified 1,068 unique products adulterated with active pharmaceutical ingredients (APIs).¹ The most common categories of contamination:

• Sexual enhancement supplements: spiked with sildenafil (Viagra), tadalafil (Cialis), or vardenafil. Life-threatening in patients on nitrates.
• Weight-loss supplements: spiked with sibutramine, a drug removed from the US market in 2010 for cardiovascular harm. Also spiked with phenolphthalein (a banned laxative) and undeclared stimulants.
• Muscle-building supplements: spiked with synthetic anabolic steroids, designer SARMs, and androgen precursors. Up to 89% of samples in some categories contained synthetic steroids.¹

The FDA has increasingly focused its surveillance sampling on online sources and international mail shipments. 38.6% of adulterated samples in the recent FDA data were identified through online sampling.¹ Importantly, the authors of the analysis note that this may reflect FDA sampling priorities (online channels are known higher-risk) as much as true prevalence - which itself underscores that online sourcing is treated by regulators as the higher-risk pathway. A separate analysis of the FDA Office of Criminal Investigation database (2016-2021) found that 64.6% of enforcement actions against drug counterfeiters involved products sold over the internet, and in 84.6% of cases the counterfeit products could be obtained without a prescription.² One-third of these enforcement actions involved products sold as dietary supplements.

Mislabeling in mainstream online channels

Independent testing of products purchased from established online platforms shows substantial mislabeling rates even when the platform has implemented quality requirements.

• Amazon immune-support supplements: A JAMA Network Open analysis tested 30 products marketed to "support" or "boost" the immune system. 17 of 30 (57%) had inaccurate labels: 13 were misbranded (listed ingredients not detected), 9 contained undeclared substances, and none carried third-party certification seals.³
• Hemp-derived topical CBD products: A separate JAMA Network Open analysis of 105 products found that only 24% were accurately labeled (within ±10% of stated CBD content). The deviation range was substantially wider for online products (-96% to +121%) than for in-store products (-75% to +93%).⁴ A larger analysis of 516 CBD products found only 42% within ±10% of label claim, with 40% containing less than 90% of the claimed amount.⁵
• CBD heavy metal contamination: Among 202 commercially available CBD products, 74% deviated from label claim by at least 10%. Heavy metals were detected in 44 products (lead most prevalent), residual solvents in 181 of 202, and pesticides in 30 products. Some violated regulatory thresholds.⁶

The CBD numbers are not an aberration. They reflect the difficulty of quality control in any product category that grew rapidly under DSHEA without a parallel regulatory framework.

Botanical adulteration: the unglamorous middle of the supplement aisle

Botanical adulteration - substitution of the labeled herb with cheaper or different plant material, often with no toxic intent but with no therapeutic correspondence either - is endemic in the herbal supplement category. A comprehensive review of 5 popular botanicals (2,995 samples from 78 publications) found striking rates:⁷

Botanical	Samples tested	Adulteration rate
Ginkgo leaf	533	56.7%
Black cohosh rhizome	322	42.2%
Echinacea root/herb	200	28.5%
Elder berry	695	17.1%
Turmeric root/rhizome	1,247	16.5%

A separate finding from the same body of literature: products sold as licensed or registered herbal medicines have lower adulteration rates than products sold as dietary/food supplements. The latter is the category that dominates the US online supplement market. The clinical implication is that even when a patient has a real reason to take a botanical (anti-inflammatory effect, sleep, immune support), the product they buy on Amazon or Instagram may not contain a therapeutic dose of the labeled herb - or may not contain the herb at all.

Proprietary blends are the structural problem

A specific quality-erosion mechanism worth naming: proprietary blends. These are mixtures of multiple ingredients listed by total blend weight without individual amounts. They dominate pre-workout supplements, weight-loss products, and "wellness" stacks. Their structural effect is to make it impossible for the consumer or the clinician to know how much of any single ingredient is present. Several consequences flow from this:

• Active dosing is unknown, so therapeutic effect cannot be evaluated.
• Drug interactions cannot be predicted, because the doses of interacting ingredients are unknown.
• Adverse event investigation is structurally hobbled: if a patient develops liver injury on a multi-ingredient blend with 12 components, identifying the culprit is far harder than for a single-ingredient product.
• "Fairy dusting": a manufacturer can include trace amounts of marketing-friendly ingredients (e.g., 1 mg of an herb that would need 500 mg to do anything) without disclosing the absurdity of the dose.

The practical filter: if the ingredient panel does not list each compound with a specific dose, treat the product with skepticism.

Dose unpredictability within a single bottle

A 2021 PLOS ONE analysis tested 29 herbal supplements for consistency between bottles and within bottles. The finding: active compound concentrations varied by 0-120% between pills within the same bottle.⁸ This is the practical end of poor manufacturing controls. When the variance between pills is greater than 100% of the mean, any therapeutic dosing strategy is unreliable on its face. Sealed-system Good Manufacturing Practice (cGMP) compliance under 21 CFR 111 is supposed to prevent this. The FDA conducts cGMP inspections, but resources are limited and the data above demonstrate that the protection is incomplete.

Allergen and contamination findings from DNA-based testing

DNA metabarcoding - sequencing the DNA actually present in supplement capsules - has produced some of the most jarring quality-control findings:

• Undeclared nuts and wheat in herbal supplements (anaphylaxis risk).
• Undeclared animal ingredients in products marketed as plant-based, including reindeer, frog, and shrew in some Asian-imported preparations.⁹
• Substitution of the labeled botanical with related species that have different pharmacologic profiles.

For patients with known food allergies, peanut/tree nut sensitivities, or strict dietary restrictions (religious, ethical, medical), the implication is direct: a non-third-party-verified supplement is a real anaphylaxis or contamination risk.

Why social media supply chains are structurally worse

Social media commerce - Instagram brands, TikTok-promoted direct-to-consumer products, influencer-curated "stacks" - is structurally higher-risk than even Amazon for several reasons:

1. No supply chain accountability. A significant proportion of supplements distributed via online channels are absent from routine border control and surveillance. EU Rapid Alert System for Food and Feed (RASFF) notifications for supplement safety issues have increased sixfold, with the US and China as the major sources of problematic products.¹⁰
2. No third-party verification. Even Amazon began requiring certificates of analysis in December 2020 - and 57% of Amazon-tested products were still mislabeled. Social media sellers operate without this baseline.³
3. Proprietary blend dominance. The categories most heavily promoted on social media (pre-workout, weight-loss, muscle-building, "wellness") rely most heavily on proprietary blends.
4. Influencer-driven purchasing bypasses critical evaluation. Among Austrian youth aged 15-25, 31.2% had purchased dietary supplements based on influencer recommendations, with parasocial relationships - not product quality - being the strongest predictor of purchasing behavior.¹¹ A German survey found that social media-exposed users took more supplements, more frequently, and rated their benefit higher.¹²
5. Counterfeit operations are large-scale. FDA criminal enforcement data reveal counterfeiting operations involving tens of millions of pills and hundreds of millions of dollars in sales, with China, India, Turkey, Pakistan, and Russia as the most prevalent source countries.²

The headline pattern: the same channels that engineer the strongest expectancy (see Placebo & Social Media) also have the weakest quality controls. Both forces push in the same direction.

SARMs sold as dietary supplements

A particularly clear case of regulatory failure: selective androgen receptor modulators (SARMs) - ostarine (MK-2866), andarine, LGD-4033, RAD-140 - are unapproved investigational drugs sold openly online as "dietary supplements." A JAMA analysis tested 44 products marketed as SARMs:¹³

• Nearly half were marketed as dietary supplements despite the obvious illegality.
• Frequent mislabeling: some products contained entirely different compounds than listed.
• Cross-contamination with growth hormone secretagogues, designer steroids, and other unapproved investigational agents.

The clinical hazards are real: SARMs are associated with hepatotoxicity, lipid derangement, and HPG-axis suppression. The added quality problem is that a patient who decides to use a SARM cannot reliably know what they are actually putting in their body.

How to actually vet a supplement

The three-step practical version:

1. Look for an independent third-party verification seal. The trustworthy ones are:
   • USP Verified (United States Pharmacopeia): tests for identity, potency, purity, and manufacturing controls.
   • NSF Certified for Sport (NSF International): tests for purity and for substances banned by sport governing bodies.
   • ConsumerLab.com Approved Quality Product: independent batch testing.
   • IFOS (International Fish Oil Standards): specific to fish oil; tests for purity, oxidation, and EPA/DHA content.
   • Informed Sport / Informed Choice: specific to sport supplements; tests against the WADA prohibited list. No seal? Treat the product with skepticism. The seals themselves are not perfect (paid-program audits can be gamed), but their absence is a clearer red flag than their presence is a clean green light.
2. Skip proprietary blends. If the panel says "Energy Blend: 1,200 mg" without listing each ingredient's individual dose, the product is structurally opaque. Walk away.
3. Be wary of brands that exist only through social media. A brand without a customer service phone number, a physical address, or a presence at established retailers is operating in a supply chain that the FDA, the EU RASFF, and the established supplement industry's own quality controls cannot easily reach. The chance that the product is mislabeled or adulterated is higher in that channel by structural design.

How we handle this in clinic

Our practical pattern with patients:

• Photograph everything. We ask patients to bring photos of every supplement they are currently taking. The goal is to inventory before we recommend any changes.
• Test against the indication. For each supplement, we ask: what problem is this fixing? Can we measure that problem? If yes, we measure it.
• Stop the unbranded, unverified, and unindicated. Most patients walk in with 8-15 supplements. Most walk out with 3-5. The deletions are usually the proprietary blends, the social-media-purchased one-offs, and the legacy supplements that no one has revisited in years.
• Match the survivors to a verified brand. If the supplement passes our clinical filter, we look for a USP/NSF/ConsumerLab/IFOS-verified version. If one does not exist, we treat the product with extra skepticism.
• Recheck the markers. 8-12 weeks after the new regimen starts, we re-measure the targeted biomarker. If it has not moved, the supplement is most likely not contributing, and we deprescribe.

For the framework we use to decide which supplements meet our bar in the first place, see How We Choose Supplements and Supplement Safety and Independent Testing.

Key Takeaways

• 40-75% of supplements deviate from their labeled content by more than 10% across independent testing studies in mainstream channels.
• The FDA tainted supplements database holds more than 1,000 products spiked with pharmaceutical ingredients including sibutramine, sildenafil, and synthetic steroids.
• Botanical adulteration rates range from 17% (turmeric) to 57% (ginkgo) across 2,995 tested samples.
• Proprietary blends are the structural enemy of dose transparency. Skip them.
• Online and social media supply chains are structurally higher-risk than retail channels by every measure available (FDA enforcement targeting, third-party verification rates, supply chain accountability).
• Look for USP, NSF, ConsumerLab, or IFOS verification. The absence of a seal is a clearer red flag than the presence of a seal is a guarantee.
• Be especially wary of muscle-building, weight-loss, sexual enhancement, and detox products - these categories have the highest adulteration rates in independent testing.
• The combination of placebo amplification on social media (see the companion piece) and weakest quality controls in social media supply chains is what makes social-media-sourced supplements particularly hazardous.

Scientific References

1. White CM. Continued Risk of Dietary Supplements Adulterated With Approved and Unapproved Drugs: Assessment of the US Food and Drug Administration's Tainted Supplements Database 2007 Through 2021. J Clin Pharmacol. 2022. 2. White CM. Criminal Action Against Drug Counterfeiters: Assessment of the FDA Office of Criminal Investigation Database 2016 Through 2021. Ann Pharmacother. 2022. 3. Crawford C, Avula B, Lindsey AT, et al. Analysis of Select Dietary Supplement Products Marketed to Support or Boost the Immune System. JAMA Netw Open. 2022. 4. Spindle TR, Sholler DJ, Cone EJ, et al. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores. JAMA Netw Open. 2022. 5. Gidal BE, Vandrey R, Wallin C, et al. Product Labeling Accuracy and Contamination Analysis of Commercially Available Cannabidiol Product Samples. Front Pharmacol. 2023. 6. Gardener H, Wallin C, Bowen J. Heavy Metal and Phthalate Contamination and Labeling Integrity in a Large Sample of US Commercially Available Cannabidiol (CBD) Products. Sci Total Environ. 2022. 7. Orhan N, Gafner S, Blumenthal M. Estimating the Extent of Adulteration of the Popular Herbs Black Cohosh, Echinacea, Elder Berry, Ginkgo, and Turmeric: Its Challenges and Limitations. Nat Prod Rep. 2024. 8. Veatch-Blohm ME, Chicas I, Margolis K, et al. Screening for Consistency and Contamination Within and Between Bottles of 29 Herbal Supplements. PLoS One. 2021. 9. Crighton E, Coghlan ML, Farrington R, et al. Toxicological Screening and DNA Sequencing Detects Contamination and Adulteration in Regulated Herbal Medicines and Supplements for Diet, Weight Loss and Cardiovascular Health. J Pharm Biomed Anal. 2019. 10. Petroczi A, Taylor G, Naughton DP. Mission Impossible? Regulatory and Enforcement Issues to Ensure Safety of Dietary Supplements. Food Chem Toxicol. 2011. 11. Engel E, Gell S, Karsay K, Heiss R. Engagement With Influencers as Sources of Health Information and Product Promotions: A Cross-Sectional Survey of Austrian Youth Aged 15-25 Years. J Adolesc Health. 2025. 12. Obstfeld H, Lohmann M. Food Supplements in the Context of Social Media: Results From a Survey on Use and Perceptions in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025. 13. Van Wagoner RM, Eichner A, Bhasin S, Deuster PA, Eichner D. Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet. JAMA. 2017.

Medical Disclaimer

This article is for educational purposes only and is not medical advice for any individual. Decisions about starting, stopping, or changing supplements should be made with your own physician, particularly if you take prescription medications, have a chronic illness, are pregnant, or are nursing. If you suspect a supplement-related adverse event, report it to MedWatch (the FDA's adverse event reporting system) and contact your physician.